BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.300
0.00 (0.00%)
Sep 10, 2026, 5:28 PM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 34.07 million as of September 11, 2026. Its market cap has decreased by -36.56% in one year.
Market Cap
34.07M
Enterprise Value
27.26M
Revenue
4.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
ChartMarket Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 34.07M, an increase of 20,800.29%. That is a compound annual growth rate of 31.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 34.07M | -18.43% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 202.09M |
| Matricelf | 80.79M |
| Clal Biotechnology Industries | 40.31M |
| BioLight Life Sciences | 26.35M |
| XTL Biopharmaceuticals | 25.16M |
| Evogene | 24.46M |
| Purple Biotech | 18.65M |
| Can-Fite BioPharma | 14.84M |